Cristiana Campa PhD GSK

Cristiana Campa currently works at GSK as External CMC Intelligence Lead, with more than 20 years’ experience in Chemistry, Manufacturing and Control (CMC) for biologics research and development. She is actively promoting dialogue across industry and with Regulatory Agencies on several topics, including innovative technologies, specifications setting, stability, accelerated development, and pandemic preparedness. For instance, she has been co-chair, committee member and speaker in several PDA events, co-author of the PDA Technical Report 89, and co- editor of a PDA cross-company book on Quality by Design (QbD). In 2023, she has joined the PDA Board of Directors (cycle 2023-2025), and, since 2024, she is the EFPIA lead in the ICH Expert Working Group for ICH Q6 (specifications) Guideline revision, co-chair of the PDA Vaccine Interest Group, and chair of the Vaccines Europe/ IFPMA CMC Adaptive Pathways team. Since 2025, she is a member of the Vaccines Expert Committee of the US Pharmacopoeia. After her PhD and Post-Doc in Chemistry, she has held several leadership roles including Head of Research Laboratory at Bracco Imaging, Head of Analytical Development at Novartis Vaccines, Head of QbD Integration, and Head of Science and Development Practices, and Global Advisor in Technical R&D at GSK Vaccines.